MetLife Investment Management’s Ventyx Biosciences VTYX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-26,731
| Closed | -$58.5K | – | 2827 |
|
|
2024
Q4 | $58.5K | Buy |
26,731
+11,543
| +76% | +$25.3K | ﹤0.01% | 2727 |
|
|
2024
Q3 | $33.1K | Sell |
15,188
-18,207
| -55% | -$39.7K | ﹤0.01% | 2796 |
|
|
2024
Q2 | $77.1K | Buy |
33,395
+8,339
| +33% | +$19.3K | ﹤0.01% | 2690 |
|
|
2024
Q1 | $138K | Buy |
+25,056
| New | +$138K | ﹤0.01% | 2382 |
|
|
2023
Q4 | – | Sell |
-24,841
| Closed | -$863K | – | 2866 |
|
|
2023
Q3 | $863K | Hold |
24,841
| – | – | 0.01% | 1312 |
|
|
2023
Q2 | $815K | Buy |
24,841
+11,815
| +91% | +$388K | 0.01% | 1385 |
|
|
2023
Q1 | $436K | Hold |
13,026
| – | – | ﹤0.01% | 1725 |
|
|
2022
Q4 | $427K | Hold |
13,026
| – | – | ﹤0.01% | 1741 |
|
|
2022
Q3 | $455K | Hold |
13,026
| – | – | ﹤0.01% | 1707 |
|
|
2022
Q2 | $159K | Buy |
+13,026
| New | +$159K | ﹤0.01% | 2456 |
|